Safety and acceptability of transcranial direct current stimulation for the acute treatment of major depressive episodes: Analysis of individual patient data.

[1]  F. Fregni,et al.  A Systematic Review on the Acceptability and Tolerability of Transcranial Direct Current Stimulation Treatment in Neuropsychiatry Trials , 2016, Brain Stimulation.

[2]  Leigh E. Charvet,et al.  Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016 , 2016, Brain Stimulation.

[3]  A. Carvalho,et al.  The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature , 2016, Psychotherapy and Psychosomatics.

[4]  Frank Padberg,et al.  Transcranial direct current stimulation for acute major depressive episodes: Meta-analysis of individual patient data , 2016, British Journal of Psychiatry.

[5]  S. Leucht,et al.  Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. , 2016, JAMA psychiatry.

[6]  E. Haffen,et al.  Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram , 2015, Clinical Neurophysiology.

[7]  Frank Padberg,et al.  The Role of Contact Media at the Skin-electrode Interface During Transcranial Direct Current Stimulation (tDCS) , 2014, Brain Stimulation.

[8]  F. Fregni,et al.  The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. , 2013, JAMA psychiatry.

[9]  Paul B. Fitzgerald,et al.  A Randomized Double-Blind Sham-Controlled Study of Transcranial Direct Current Stimulation for Treatment-Resistant Major Depression , 2012, Front. Psychiatry.

[10]  H. Möller,et al.  Transcranial direct current stimulation in treatment resistant depression: A randomized double-blind, placebo-controlled study , 2012, Brain Stimulation.

[11]  Donel M. Martin,et al.  Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial , 2012, British Journal of Psychiatry.

[12]  Gin S Malhi,et al.  A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. , 2010, The international journal of neuropsychopharmacology.

[13]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[14]  N. D. Morton.  The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. , 2009 .

[15]  T. Kashdan,et al.  Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events , 2008, European Journal of Clinical Pharmacology.

[16]  Maurizio Fava,et al.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. , 2006, The New England journal of medicine.

[17]  M. Nitsche,et al.  Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans , 2001, Neurology.

[18]  J. Anthony,et al.  Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. , 1997, Archives of general psychiatry.

[19]  F. Song,et al.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. , 1993, BMJ.